Brief: Rallybio Corporation Reports Third Quarter 2021 Financial Results And Recent Business Highlights
10/11/2021 12:08
Nov 10 (Reuters) - Rallybio Corp RLYB.O :
* ORATION REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
RECENT
BUSINESS HIGHLIGHTS
* Q3 LOSS PER SHARE $0.37
Source text for Eikon: ID:nBw69nxWga
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx